239 related articles for article (PubMed ID: 19674446)
1. Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study.
Panegyres PK; Rogers JM; McCarthy M; Campbell A; Wu JS
BMC Neurol; 2009 Aug; 9():41. PubMed ID: 19674446
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
[TBL] [Abstract][Full Text] [Related]
3. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
[TBL] [Abstract][Full Text] [Related]
4. Impact of molecular imaging on the diagnostic process in a memory clinic.
Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
[TBL] [Abstract][Full Text] [Related]
5. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
Shea YF; Ha J; Lee SC; Chu LW
Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.
Vijverberg EG; Wattjes MP; Dols A; Krudop WA; Möller C; Peters A; Kerssens CJ; Gossink F; Prins ND; Stek ML; Scheltens P; van Berckel BN; Barkhof F; Pijnenburg YA
J Alzheimers Dis; 2016 Jun; 53(4):1287-97. PubMed ID: 27372646
[TBL] [Abstract][Full Text] [Related]
7. Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [
Hellwig S; Frings L; Bormann T; Vach W; Buchert R; Meyer PT
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):312-323. PubMed ID: 30094462
[TBL] [Abstract][Full Text] [Related]
8. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
Koeppe RA; Gilman S; Joshi A; Liu S; Little R; Junck L; Heumann M; Frey KA; Albin RL
J Nucl Med; 2005 Jun; 46(6):936-44. PubMed ID: 15937303
[TBL] [Abstract][Full Text] [Related]
9. Evaluating 2-[
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia.
Nuvoli S; Tanda G; Stazza ML; Madeddu G; Spanu A
Dement Geriatr Cogn Disord; 2019; 48(5-6):250-260. PubMed ID: 32062656
[TBL] [Abstract][Full Text] [Related]
11. Clinical Relevance of [
Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938
[TBL] [Abstract][Full Text] [Related]
12. Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders.
Minoshima S; Mosci K; Cross D; Thientunyakit T
Semin Nucl Med; 2021 May; 51(3):230-240. PubMed ID: 33546814
[TBL] [Abstract][Full Text] [Related]
13. FDG PET imaging in patients with pathologically verified dementia.
Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
[TBL] [Abstract][Full Text] [Related]
15. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
[TBL] [Abstract][Full Text] [Related]
16. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
Kono AK; Ishii K; Sofue K; Miyamoto N; Sakamoto S; Mori E
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1490-7. PubMed ID: 17318545
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
Tripathi M; Tripathi M; Damle N; Kushwaha S; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
[TBL] [Abstract][Full Text] [Related]
18. Management impact of FDG-PET in dementia: results from a tertiary center memory clinic.
Elias A; Woodward M; Rowe CC
J Alzheimers Dis; 2014; 42(3):885-92. PubMed ID: 24961944
[TBL] [Abstract][Full Text] [Related]
19. Frontal network syndrome testing: clinical tests and positron emission tomography brain imaging help distinguish the 3 most common dementia subtypes.
Hoffmann M
Am J Alzheimers Dis Other Demen; 2013 Aug; 28(5):477-84. PubMed ID: 23677732
[TBL] [Abstract][Full Text] [Related]
20. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
Silverman DH
J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]